Biosimilar monoclonal antibodies: the scientific basis for extrapolation.

Biosimilar monoclonal antibodies: the scientific basis for extrapolation.

Item
http://www.wikidata.org/entity/Q38586044
Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published EvidenceMonoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published EvidenceControversies in Establishing Biosimilarity: Extrapolation of Indications and Global Labeling Practices.Biosimilar epoetin zeta: extrapolation of indications and real world utilization experience.Advanced assessment of the physicochemical characteristics of Remicade® and Inflectra® by sensitive LC/MS techniques.Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM).The surge in biosimilars: considerations for effective pharmacovigilance and EU regulationBiosimilars in oncology and inflammatory diseases: current and future considerations for clinicians in Latin America
P2860

Biosimilar monoclonal antibodies: the scientific basis for extrapolation.

Item
http://www.wikidata.org/entity/Q38586044
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Biosimilar monoclonal antibodies: the scientific basis for extrapolation.
@en
type
label
Biosimilar monoclonal antibodies: the scientific basis for extrapolation.
@en
prefLabel
Biosimilar monoclonal antibodies: the scientific basis for extrapolation.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Biosimilar monoclonal antibodies: the scientific basis for extrapolation.
@en
P2093
P2860
P304
P31
P356
10.1517/14712598.2015.1083552
P407
P433
P478
P577
P698